📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
HOMECOVERAGETARS › EARNINGS
EARNINGS HUB
News Coverage Earnings Hub Earnings Report Grades
$TARS
TARS Earnings: Miss 2/4 · 4 quarters tracked
LAST 30 DAYS
5 articles
AVG GRADE
HIGH
score: 0.50
SENTIMENT
TOTAL VIEWS
19
◈ EARNINGS HUB · 2026-06

TARS Earnings: Miss, Surprise History & Forecast

2/4 quarters beaten · Last EPS $-0.49 (+-145.1%) · AI Grade: HIGH
◈ ESEN AI · EARNINGS PREVIEW
TARS reported EPS of $-0.49 in its most recent quarter (2026-06), missing consensus estimate of $-0.20 by -145.1%. Over the last 4 quarters, the company has beaten estimates 2 times (50% beat rate) with an average surprise of +-44.4%. ESEN AI grade: HIGH.
LAST EPS
$-0.49
est $-0.20
LAST SURPRISE
-145.1%
2026-06
BEAT RATE
2/4
beats / quarters
AVG SURPRISE
-44.4%
last 4Q
◆ EPS MOMENTUM
PERIOD
ACTUAL EPS
ESTIMATE
SURPRISE
2026-06-30
$-0.49
$-0.20
-145.1%
2026-03-31
$-0.16
$-0.38
+57.6%
2025-12-31
$-0.20
$-0.10
-106.2%
2025-09-30
$-0.30
$-0.36
+16.1%
◈ RELATED EARNINGS NEWS
seekingalpha
2026-08-06
Tarsus Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:TARS) 2026-08-06
NEUTRAL
SeekingAlpha
2026-08-06
Tarsus Pharmaceuticals to buy Alkeus Pharmaceuticals
NEUTRAL
manilatimes.
2026-08-06
Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing
NEUTRAL
GlobalNewswi
2026-08-06
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position
NEUTRAL
seekingalpha
2026-07-24
Tarsus Pharmaceuticals: Q2 2026 Rebound In Sales Possible, Catalysts Approaching (TARS)
NEUTRAL
View all TARS news →
◈ FREQUENTLY ASKED QUESTIONS
When did $TARS last report earnings?
TARS last reported earnings on 2026-06-30, with actual EPS of $-0.49 vs estimate of $-0.20.
Did $TARS beat earnings estimates?
No, TARS missed consensus EPS by -145.1%.
What is $TARS's earnings beat rate?
TARS has beaten consensus EPS in 2 of 4 quarters (50%). Average surprise: +-44.4%.
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours. Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice